These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 18069256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
    Tichý M, Maisnar V, Palicka V, Friedecký B, Vávrová J, Novotná H, Cermáková Z, Dastych M, Cechák P, Vogtová D, Jarolímková E, Benáková H, Hachová L, Bezdícková D, Kouril F, Zábranská EA, Zenková J, Slabý P, Scudla V, Gregora E, Spicka I, Straub J, Schützova M, Hájek R.
    Neoplasma; 2006; 53(6):492-4. PubMed ID: 17167717
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V, Zemanova M, Minarik J, Bacovsky J, Ordeltova M, Indrak K, Budikova M, Dusek L, Farbiakova V.
    Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications.
    Pasqualetti P, Colantonio D, Collacciani A, Casale R, Natali G.
    Panminerva Med; 1991; 33(2):93-110. PubMed ID: 1923560
    [Abstract] [Full Text] [Related]

  • 15. [Biochemical and immunological findings of multiple myeloma].
    Asaoku H.
    Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270
    [Abstract] [Full Text] [Related]

  • 16. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG.
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [Abstract] [Full Text] [Related]

  • 17. [Prognostic factors of multiple myeloma].
    Paule B.
    Ann Med Interne (Paris); 1997 Jul; 148(8):534-41. PubMed ID: 9538400
    [Abstract] [Full Text] [Related]

  • 18. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
    Scudla V, Budíková M, Fischerová E, Zadrazil J, Indrák K.
    Acta Univ Palacki Olomuc Fac Med; 1991 Jul; 130():201-12. PubMed ID: 1838869
    [Abstract] [Full Text] [Related]

  • 19. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F, Minoia C, Favoino E, Prete M, Dammacco F.
    Blood Cells Mol Dis; 2009 Jul; 42(1):71-6. PubMed ID: 18996035
    [Abstract] [Full Text] [Related]

  • 20. Analysis of criteria in staging in multiple myeloma.
    Pennec Y, Mottier D, Youinou P, Asselain B, Miossec P, Le Goff P, Le Prise PY, Le Menn G.
    Haematologia (Budap); 1982 Jul; 15(2):221-6. PubMed ID: 7160667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.